NYSE · Common Stock · Surgical & Medical Instruments & Apparatus
American manufacturer of healthcare goods
33 entities across 23 jurisdictions. Read directly from the company’s own 10-K EX-21 filed 2026-02-12 — see the exhibit.
Which other public companies file entities in the same places:
| Entity | Jurisdiction | Note |
|---|---|---|
| Baxter Healthcare Corporation | Delaware | |
| Baxter Healthcare of Puerto Rico LLC | Delaware | |
| Hill-Rom Services, Inc. | Indiana | |
| Welch Allyn Inc. | New York | |
| Laboratorios Baxter S.A. | Delaware | |
| Synovis Micro Companies Alliance, Inc. | Minnesota | |
| Baxter Healthcare Pty Ltd | Australia | |
| Baxter Belgium SPRL | Belgium | |
| Baxter Distribution Center Europe SA | Belgium | |
| Baxter R and D Europe SPRL | Belgium | |
Two standard screens, computed from the XBRL in FY2025 against FY2024. Every test shows the numbers behind it — a score with its inputs hidden is a number you cannot check.
Bankruptcy-risk screen combining working capital, retained earnings, operating income, market value against liabilities, and asset turnover. Above 2.99 is the safe zone; below 1.81 is distress.
| Year | Revenue | Net income | Free cash flow | Gross margin | Shares |
|---|---|---|---|---|---|
| FY2020 | $11.7B | $1.1B | $1.2B | 39.3% | 517,000,000 |
| FY2021 | $12.8B | $1.3B | $1.5B | 39.9% | 508,000,000 |
| FY2022 | $15.1B | −$2.4B | $532.0M | 35.7% | 504,000,000 |
| FY2023 | $14.8B | $2.7B | $1.0B | 33.6% | 506,000,000 |
| FY2024 | $10.6B | −$649.0M | $573.0M | 37.5% | 510,000,000 |
1 institutions tracked — 1 added, 0 reduced.
| Manager | Kind | Shares | Change | Value |
|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | Index | 14,123,689 | +360,724 | $300.6M |
From 13F filings, which cover institutions managing over $100m and are filed up to 45 days after the quarter ends — so this is a considered position, not a live one, and it is not the whole shareholder register.
What the company actually paid out and bought back, as reported — the record behind any yield figure.
Ownership percentages are a vendor aggregate, not a filing — unlike everything else on this page.
BAXTER INTERNATIONAL INC files under SIC 3841 — all 38 surgical & medical instruments & apparatus companies compared on assets and F-score.
The structure map above is the Corporate Blueprint, and in the desktop it is interactive — click any entity to re-centre the map on it and walk the ownership chain. It sits alongside the screener, the scorecard and the filings lab on one desk, on your machine.
Sourced from SEC EDGAR primary filings. Figures are as reported by the company and are not investment advice. Scores are standard published screens computed from those filings; every input is shown above so you can check the arithmetic.
| Baxter SA |
| Belgium |
| Baxter Hospitalar Ltda. | Brazil |
| Baxter Corporation (Canada) | Canada |
| Baxter Healthcare (Shanghai) Company Ltd. | China |
| Baxter S.A.S. | France |
| Baxter Deutschland GmbH | Germany |
| Baxter Healthcare Limited (Hong Kong, China) | Hong Kong |
| Baxter Pharmaceuticals India Pvt Ltd. | India |
| Baxter Innovations & Business Solutions Private Limited (India) | India |
| Baxter Shared Services & Competencies Limited | Ireland |
| Baxter Healthcare S.A.- Ireland Finance Branch | Ireland |
| Baxter S.p.A. | Italy |
| Baxter Healthcare Limited | New Zealand |
| Baxter Polska Sp. z o.o. | Poland |
| Baxter Healthcare SA (Singapore Woodlands Branch) | Singapore |
| Baxter Pharmaceuticals (Asia) Pte Ltd. | Singapore |
| Baxter, S.L. | Spain |
| Baxter AG | Switzerland |
| Baxter Healthcare SA | Switzerland |
| Baxter Healthcare Limited (Taiwan) | Taiwan |
| Baxter Holding B.V. | The Netherlands |
| Baxter Netherlands Holding B.V. | The Netherlands |
| Baxter Turkey Renal Hizmetler A.S | Turkey |
| FY2025 |
| $11.2B |
| −$957.0M |
| $332.0M |
| 30.1% |
| 513,000,000 |